Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Diversification is a key tool to dampen volatility in retirement portfolios. This note outlines practical allocation strategies and real-world scenarios.
26,772 articlesIonis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
When a Planet Labs CEO sells shares, investors take note. This article breaks down what the move could signal, how to...
Tesla's robotaxi just launched in Miami, marking a milestone for autonomous transport. Yet the pilot comes with a del...
FTX launches a $900 million creditor payout on July 31 to eligible holders, while 45 jurisdictions remain blocked fro...
Meta Platforms unveils a multi-year AI infrastructure plan with Nvidia valued around $115 billion to $135 billion for...
Brazil slashes import duties for a narrow class of Bitcoin mining hardware as Engie explores a pilot at a large solar...
Bilt rolls out an AI-driven Neighborhood Concierge to challenge Amazon in the home-commerce space, promising seamless...
A high-profile privacy battle shines a light on how personal finance and privacy intersect. Learn practical steps to ...
When a celebrity’s home is hit by gunfire in broad daylight, the headlines tell a story of fear. This article transla...
When a cybersecurity giant bets $25 billion on a single platform, investors should understand the why, the potential ...
A colossal DeFi trade on AAVE's swap interface left a trader facing a near $50 million loss after a mispriced swap. R...
WM Technology MAPS is weighing a pivotal year. This guide breaks down the Q4 2025 earnings, what technology (maps) 20...